the mutants resistant to both of these drugs showed significantly increased resistance toward aclarubicin , dactinomycin , doxorubicin , bisantrene , bruceantin , chromomycin a3 , demecolcine , colchicine , daunorubicin , ellipticine , emetine , ethidium bromide , maytansine , mithramycin , mitoxantrone , nitidine chloride , olivomycin , podophyllotoxin , puromycin , taxol , vinblastine , vincristine , vindesine , teniposide , and etoposide .
C0013089
doxorubicin
C0011015
daunorubicin